Prostate Cancer Clinical Trials in Salt Lake City

Showing 41-60 of 168 trials

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

NCT01995058

This study was conducted in subjects in chemotherapy-naïve subjects with bone-metastatic castration-resistant prostate cancer (CRPC).

Prostate CancerCastration Resistant Prostate CancerProstatic Neoplasms

Exelixis54 participantsStarted Feb 2014

Scottsdale, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +17 more locations

TERMINATEDPHASE2< 1 mile

Massage for Prostate Cancer-Related Fatigue (mPROSTATE)

NCT05067777

This phase II trial investigates the effect of massage in decreasing prostate cancer-related fatigue. Massage therapy has well known health benefits. This trial aims to find out if massage and touch therapies reduce fatigue due to cancer, and to learn if these therapies are better than traditional medicine or psychology for cancer related fatigue.

Prostate Carcinoma

University of Utah28 participantsStarted Jun 2022

Salt Lake City, Utah, United States

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

Massage for Prostate Cancer-Related Fatigue (mPROSTATE)

Prostate Cancer Trials in Other Cities

Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection

QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

Other Conditions in Salt Lake City